An overview of the latest news in Parkinson disease reported across MJH Life Sciences™.
An overview of the latest news in Parkinson disease (PD) reported across MJH Life Sciences™.
COVID-19 Neurological Complications Linked With Mortality, Longer Hospital Stay
Patients with neurological conditions such as PD, Alzheimer disease (AD), and all-cause dementia have been shown in prior research to be at greater risk of COVID-19 disease severity and death, and a study highlighted by NeurologyLive® finds that neurological manifestations caused by the virus may also significantly increase risk of mortality and functional decline in patients.
Individuals who developed neurological complications of COVID-19 were shown to be of older age and stay in hospitals more than 2-fold longer, on average, compared with regular patients, and they were also associated with more frequent discharge to a subacute rehabilitation facility.
Notably, research presented this week at the Alzheimer’s Association International Conference indicated that brain fog, a long-term neurological symptom of COVID-19, may increase the risk of developing AD.
Integrating Novel Technology in Management of Advanced PD
In a Peer Exchange series by NeurologyLive®, titled “Recognizing and Managing Advanced Parkinson Disease,” panelists discussed the use of technology in the management of advanced PD and how to optimally integrate these devices into practice.
Addressing approaches to incorporate technology in the management of PD, panelists mentioned 2 ways to do so: the use of wearable technology and the use of smart homes. Smart homes, which function by having devices planted in the house to track the motor behavior of patients, were regarded as an experimental approach still currently under investigation.
Furthermore, the use of deep-brain stimulation and in-brain sensing was noted, which may open possibilities for adaptive devices that would alter or administer doses based on a patient’s dopamine levels.
Cause for Most Common Form of PD Identified
In a recent study by researchers from the University of Copenhagen, the most common form of PD, sporadic PD, was found to be caused by the blockage of a pathway that regulates the mitochondria.
Published in Molecular Psychiatry, the blockage was noted to be caused by a dysregulation of the immune genes, particularly the type 1 interferon, which causes neurons to gradually die and lead to the development of PD and associated dementia.
Following their findings, researchers said they hope the study will serve as a catalyst for further research on the blockage and how to counteract it. Moreover, they noted that future research conducted by their team will focus on how the pathway contributes to neuronal homeostasis and survival, and how its dysregulation causes neuronal cell death.
Prices for care at hospital trauma centers vary across hospitals; drug shortages reached a record high during the first quarter of 2024; although 3 of the biggest makers of asthma inhalers pledged to cap out-of-pocket costs for some US patients at $35, these do not apply to daily inhalers used by the youngest kids with asthma.
Read More
Navigating Medicare's Part D Subsidy Program to Achieve Value-Based Care
May 26th 2023On this episode of Managed Care Cast, we speak with the lead researcher from a study published in the May 2023 issue of The American Journal of Managed Care® about the impact of low-income subsidies on the uptake and equitable use of expensive orally administered antimyeloma therapy.
Listen
AHN’s Center for Inclusion Health Personalizing Equitable Care Delivery for Marginalized Communities
February 28th 2023On this episode of Managed Care Cast, we speak with Elizabeth Cuevas, MD, division chief of Allegheny Health Network’s (AHN) Center for Inclusion Health, on prevalent health inequities facing marginalized communities and strategies to identify and address these issues.
Listen
Health Equity Adjustments in Medicare HVBP Program Will Benefit Safety Net Hospitals, Study Says
March 29th 2024Medicare’s upcoming health equity adjustment in the Hospital Value-Based Purchasing (HVBP) program will reduce disproportionate penalization among safety net hospitals and those serving high proportions of Black patients, according to a recent study.
Read More